Chittorgarh.com Logo
Loading...

Windlas Biotech Limited IPO (Windlas Biotech IPO) Detail

Aug 4, 2021 - Aug 6, 2021

Incorporated in 2001, Windlas Biotech Ltd is one of the leading companies in the pharmaceutical formulations contract development and manufacturing organizations (CDMO) segment in India. The company offers a range of CDMO services from product discovery to product development, licensing, and commercial manufacturing of generic products including complex generics.

It further sells its own branded products in the trade generics and OTC markets. Currently, the focus of the company is to launch complex generic products in the chronic therapeutic category related to lifestyle-related disorders. The business operates in 3 verticals; 1. CDMO Products and services, 2. Domestic trade generics and Over-the-counter (OTC) market (nutraceutical and health supplement products), and 3. Export.

Leading pharma companies i.e. Pfizer Ltd, Sanofi India Ltd, Cadila Healthcare Ltd, Emcure Pharmaceuticals Ltd, Eris Lifesciences Ltd, Intas Pharmaceuticals Ltd, and Systopic Laboratories Private Limited are some of the marquee customers of Windlas Biotech. Its manufacturing facilities are located at Dehradun with an installed operating capacity of 7,063.83 million tablets/ capsules, 54.46 million pouch/ sachet, and 61.08 million liquid bottles.

Competitive strengths

  • Leading market player in the domestic pharmaceutical formulation CDMO segment.
  • Strong focus on the chronic therapeutic category.
  • state-of-the-art manufacturing facilities in Dehradun, Uttarakhand.
  • Professional and experienced Promoters and a senior management team.
  • An innovative product portfolio of complex generic products.
  • Robust financial performance track record.

Company Promoters:

Ashok Kumar Windlass, Hitesh Windlass, Manoj Kumar Windlass, and AKW WBL Family Pvt Trust are the company promoters.

Company Financials:

Summary of financial Information (Restated Consolidated)
Particulars For the year/period ended (₹ in million)
31-Mar-21 31-Mar-20 31-Mar-19
Total Assets 2,961.23 3,384.88 2,981.80
Total Revenue 4,306.95 3,313.39 3,115.25
Profit After Tax 155.70 162.13 638.22

Objects of the Issue:

  • To purchase equipment required for capacity expansion of our existing facility at Dehradun Plant IV.
  • To finance incremental working capital requirements of the company.
  • Repayment/prepayment of company's borrowings.
  • General corporate purposes.

Windlas Biotech IPO Details

IPO Opening Date Aug 4, 2021
IPO Closing Date Aug 6, 2021
Issue Type Book Built Issue IPO
Face Value ₹5 per equity share
IPO Price ₹448 to ₹460 per equity share
Market Lot 30 Shares
Min Order Quantity 30 Shares
Listing At BSE, NSE
Issue Size[.] Eq Shares of ₹5
(aggregating up to ₹401.54 Cr)
Fresh Issue[.] Eq Shares of ₹5
(aggregating up to ₹165.00 Cr)
Offer for Sale5,142,067 Eq Shares of ₹5
(aggregating up to ₹236.54 Cr)

Windlas Biotech IPO Tentative Timetable

The Windlas Biotech IPO open date is Aug 4, 2021, and the close date is Aug 6, 2021. The issue may list on Aug 17, 2021.

IPO Open Date Aug 4, 2021
IPO Close Date Aug 6, 2021
Basis of Allotment Date Aug 11, 2021
Initiation of Refunds Aug 12, 2021
Credit of Shares to Demat Account Aug 13, 2021
IPO Listing Date Aug 17, 2021

Windlas Biotech IPO Lot Size

The Windlas Biotech IPO market lot size is 30 shares. A retail-individual investor can apply for up to 14 lots (420 shares or ₹193,200).

Application Lots Shares Amount (Cut-off)
Minimum 1 30 ₹13,800
Maximum 14 420 ₹193,200

Windlas Biotech IPO Promoter Holding

Pre Issue Share Holding 78%
Post Issue Share Holding 65.16%

Windlas Biotech IPO Subscription Status (Bidding Detail)

The Windlas Biotech IPO is subscribed 22.44 times on Aug 6, 2021 18:50. The public issue subscribed 24.22 in the retail category, 24.40 in the QIB category, and 15.73 in the NII category. Check Day by Day Subscription Details (Live Status)

Application Wise IPO Subscription (Retail): 20.63 times

CategorySubscription (times)
QIB

24.40

NII

15.73

RII

24.22

Total

22.44

Windlas Biotech IPO Prospectus

Windlas Biotech IPO Rating

935
4.0
Rating:Rated 4.0 stars
Vote Here ...

Windlas Biotech IPO Listing Date

Listing Date Monday, August 16, 2021
BSE Script Code 543329
NSE Symbol WINDLAS
Listing In
ISIN INE0H5O01029
IPO Price ₹460 per equity share
Face Value ₹5 per equity share

Listing Day Trading Information

.
IPO Price
Open
Low
High
Last Trade
BSE
₹460.00
₹439.00
₹405.00
₹452.10
₹406.70
NSE
₹460.00
₹437.00
₹405.00
₹452.00
₹407.15

Company Contact Information

Windlas Biotech Limited
40/1, Mohabewala Industrial Area,
Dehradun, 248110

Phone: +91 135 6608000
Email: grievance@windlasbiotech.com
Website: http://www.windlasbiotech.com/

Windlas Biotech IPO Registrar

Link Intime India Private Ltd

Phone: +91-22-4918 6270
Email: windlas.ipo@linkintime.co.in
Website: http://www.linkintime.co.in

Windlas Biotech IPO FAQs

Windlas Biotech IPO is a main-board IPO of [.] equity shares of the face value of ₹5 aggregating up to ₹401.54 Crores. The issue is priced at ₹448 to ₹460 per equity share. The minimum order quantity is 30 Shares.

The IPO opens on Aug 4, 2021, and closes on Aug 6, 2021.

Link Intime India Private Ltd is the registrar for the IPO. The shares are proposed to be listed on BSE, NSE.

Zerodha customers can apply online in Windlas Biotech IPO using UPI as a payment gateway. Zerodha customers can apply in Windlas Biotech IPO by login into Zerodha Console (back office) and submitting an IPO application form.

Steps to apply in Windlas Biotech IPO through Zerodha

  1. Visit the Zerodha website and login to Console.
  2. Go to Portfolio and click the IPOs link.
  3. Go to the 'Windlas Biotech IPO' row and click the 'Bid' button.
  4. Enter your UPI ID, Quantity, and Price.
  5. ‘Submit’ IPO application form.
  6. Visit the UPI App (net banking or BHIM) to approve the mandate.

Visit Zerodha IPO Application Process Review for more detail.

The Windlas Biotech IPO opens on Aug 4, 2021 and closes on Aug 6, 2021.

Windlas Biotech IPO lot size is 30 Shares and the minimum order quantity is 30 Shares.

You can apply in Windlas Biotech IPO online using either UPI or ASBA as payment method. ASBA IPO application is available in the net banking of your bank account. UPI IPO application is offered by brokers who don't offer banking services. Read more detail about apply IPO online through Zerodha, Upstox, 5Paisa, Edelweiss, ICICI Bank, HDFC Bank and SBI Bank.

The finalization of Basis of Allotment for Windlas Biotech IPO will be done on Aug 11, 2021, and the allotted shares will be credited to your demat account by Aug 13, 2021. Check the Windlas Biotech IPO allotment status.

The Windlas Biotech IPO listing date is on Monday, August 16, 2021.

Windlas Biotech IPO Message Board

Ranked Members  Ranked Members

Loading...